Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Open Forum Infect Dis ; 10(1): ofac682, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36655187

ABSTRACT

Background: Acanthamoeba is a free-living ameba that can cause severe disease affecting the central nervous system, skin, sinuses, and other organs, particularly in immunocompromised individuals. These rare but severe infections are often fatal, yet incompletely described. Methods: Cases included were either reported to the Centers for Disease Control and Prevention (CDC) Free-Living Ameba program or published in scientific literature. Characteristics of all patients in the United States with laboratory-confirmed non-keratitis Acanthamoeba infections were described using descriptive statistics, and associations with survival were determined using χ2 and Fisher exact tests. Results: Of 173 patients identified, 71% were male and the median age was 44 years (range, 0-87 years). Of these, 26 (15%) survived. Most patients (88%) had at least 1 immunocompromising condition, most commonly human immunodeficiency virus (39%), cancer (28%), and solid organ or hematopoietic stem cell transplant (28%). Granulomatous amebic encephalitis (GAE) was the most common disease presentation (71%). Skin (46%), sinuses (29%), lungs (13%), and bone (6%) were also involved. Nearly half of patients (47%) had involvement of >1 organ system. Survival was less frequent among those with GAE (3%, P < .001) compared with cutaneous disease, rhinosinusitis, or multiorgan disease not including GAE. Of 7 who received the currently recommended treatment regimen, 5 (71%) survived. Conclusions: Non-keratitis Acanthamoeba infections occur primarily in immunocompromised individuals and are usually fatal. Survival may be associated with disease presentation and treatment. Providers who care for at-risk patients should be aware of the various disease manifestations to improve early recognition and treatment.

3.
Parasitol Res ; 119(1): 339-344, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31734864

ABSTRACT

We present the first recognized case of primary amebic meningoencephalitis (PAM) caused by Naegleria fowleri in a 15-year-old male from Bangladesh. He performed daily nasal rinsing with untreated ground water and bathed in untreated ground water or river water, which likely exposed him to N. fowleri.


Subject(s)
Central Nervous System Protozoal Infections/parasitology , Naegleria fowleri/isolation & purification , Adolescent , Animals , Bangladesh , Fatal Outcome , Fresh Water/parasitology , Humans , Male
4.
Ann Neurol ; 78(5): 722-30, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26290222

ABSTRACT

OBJECTIVE: Identification of a particular cause of meningoencephalitis can be challenging owing to the myriad bacteria, viruses, fungi, and parasites that can produce overlapping clinical phenotypes, frequently delaying diagnosis and therapy. Metagenomic deep sequencing (MDS) approaches to infectious disease diagnostics are known for their ability to identify unusual or novel viruses and thus are well suited for investigating possible etiologies of meningoencephalitis. METHODS: We present the case of a 74-year-old woman with endophthalmitis followed by meningoencephalitis. MDS of her cerebrospinal fluid (CSF) was performed to identify an infectious agent. RESULTS: Sequences aligning to Balamuthia mandrillaris ribosomal RNA genes were identified in the CSF by MDS. Polymerase chain reaction subsequently confirmed the presence of B. mandrillaris in CSF, brain tissue, and vitreous fluid from the patient's infected eye. B. mandrillaris serology and immunohistochemistry for free-living amoebas on the brain biopsy tissue were positive. INTERPRETATION: The diagnosis was made using MDS after the patient had been hospitalized for several weeks and subjected to costly and invasive testing. MDS is a powerful diagnostic tool with the potential for rapid and unbiased pathogen identification leading to early therapeutic targeting.


Subject(s)
Amebiasis/diagnosis , Amebiasis/genetics , Balamuthia mandrillaris/genetics , Meningoencephalitis/diagnosis , Meningoencephalitis/genetics , Sequence Analysis, RNA/methods , Aged , Amebiasis/cerebrospinal fluid , Animals , Brain/microbiology , DNA, Protozoan/genetics , Female , Genomics , Humans , Meningoencephalitis/cerebrospinal fluid , Polymerase Chain Reaction , Vitreous Body/microbiology
5.
PLoS One ; 7(2): e32042, 2012.
Article in English | MEDLINE | ID: mdl-22363793

ABSTRACT

The generation of affinity reagents, usually monoclonal antibodies, remains a critical bottleneck in biomedical research and diagnostic test development. Recombinant antibody-like proteins such as scFv have yet to replace traditional monoclonal antibodies in antigen detection applications, in large part because of poor performance of scFv in solution. To address this limitation, we have developed assays that use whole yeast cells expressing scFv on their surfaces (yeast-scFv) in place of soluble purified scFv or traditional monoclonal antibodies. In this study, a nonimmune library of human scFv displayed on the surfaces of yeast cells was screened for clones that bind to recombinant cyst proteins of Entamoeba histolytica, an enteric pathogen of humans. Selected yeast-scFv clones were stabilized by lyophilization and used in detection assay formats in which the yeast-scFv served as solid support-bound monoclonal antibodies. Specific binding of antigen to the yeast-scFv was detected by staining with rabbit polyclonal antibodies. In flow cytometry-based assays, lyophilized yeast-scFv reagents retained full binding activity and specificity for their cognate antigens after 4 weeks of storage at room temperature in the absence of desiccants or stabilizers. Because flow cytometry is not available to all potential assay users, an immunofluorescence assay was also developed that detects antigen with similar sensitivity and specificity. Antigen-specific whole-cell yeast-scFv reagents can be selected from nonimmune libraries in 2-3 weeks, produced in vast quantities, and packaged in lyophilized form for extended shelf life. Lyophilized yeast-scFv show promise as low cost, renewable alternatives to monoclonal antibodies for diagnosis and research.


Subject(s)
Antibodies, Monoclonal/economics , Antigens, Protozoan/immunology , Entamoeba histolytica/immunology , Freeze Drying/economics , Freeze Drying/methods , Saccharomyces cerevisiae/metabolism , Single-Chain Antibodies/immunology , Antibodies, Monoclonal/immunology , Antigens, Protozoan/economics , Costs and Cost Analysis , Fluorescent Antibody Technique , Humans , Indicators and Reagents/economics , Limit of Detection , Microscopy, Fluorescence , Molecular Probes/economics , Molecular Probes/metabolism , Protozoan Proteins/immunology , Saccharomyces cerevisiae/cytology , Single-Chain Antibodies/economics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...